In the Matter of Enterologics, Inc., Midas Medici Group Holdings, Inc., and SEFE, Inc., Order of Suspension of Trading, 35421-35422 [2015-15229]

Download as PDF Federal Register / Vol. 80, No. 118 / Friday, June 19, 2015 / Notices time within 60 days of the filing of the proposed rule change, the Commission summarily may temporarily suspend such rule change if it appears to the Commission that such action is necessary or appropriate in the public interest, for the protection of investors, or otherwise in furtherance of the purposes of the Act. IV. Solicitation of Comments Interested persons are invited to submit written data, views, and arguments concerning the foregoing, including whether the proposed rule change is consistent with the Act. Comments may be submitted by any of the following methods: office of ICE Clear Europe and on ICE Clear Europe’s Web site at https:// www.theice.com/clear-europe/ regulation. All comments received will be posted without change; the Commission does not edit personal identifying information from submissions. You should submit only information that you wish to make available publicly. All submissions should refer to File Number SR–ICEEU– 2015–011 and should be submitted on or before July 10, 2015. For the Commission, by the Division of Trading and Markets, pursuant to delegated authority.17 Robert W. Errett, Deputy Secretary. asabaliauskas on DSK5VPTVN1PROD with NOTICES Electronic Comments • Use the Commission’s Internet comment form (https://www.sec.gov/ rules/sro.shtml) or • Send an email to rule-comments@ sec.gov. Please include File Number SR– ICEEU–2015–011 on the subject line. [FR Doc. 2015–15043 Filed 6–18–15; 8:45 am] Paper Comments • Send paper comments in triplicate to Secretary, Securities and Exchange Commission, 100 F Street NE., Washington, DC 20549–1090. All submissions should refer to File Number SR–ICEEU–2015–011. This file number should be included on the subject line if email is used. To help the Commission process and review your comments more efficiently, please use only one method. The Commission will post all comments on the Commission’s Internet Web site (https://www.sec.gov/ rules/sro.shtml). Copies of the submission, all subsequent amendments, all written statements with respect to the proposed rule change that are filed with the Commission, and all written communications relating to the proposed rule change between the Commission and any person, other than those that may be withheld from the public in accordance with the provisions of 5 U.S.C. 552, will be available for Web site viewing and printing in the Commission’s Public Reference Room, 100 F Street NE., Washington, DC 20549, on official business days between the hours of 10:00 a.m. and 3:00 p.m. Copies of such filings will also be available for inspection and copying at the principal In the Matter of Neologic Animation Inc., Order of Suspension of Trading these changes do not significantly affect the substantive rights or obligations of ICE Clear Europe or its Clearing Members (or otherwise adversely affect the safeguarding of funds or securities in the custody or control of the Clearing House or for which it is responsible), and therefore would also qualify for immediate effectiveness under Rule 19b– 4(f)(4)(i), 17 CFR 240.19b–4(f)(4)(i). VerDate Sep<11>2014 19:33 Jun 18, 2015 Jkt 235001 35421 investors require a suspension of trading in the securities of the above-listed company. Therefore, it is ordered, pursuant to Section 12(k) of the Securities Exchange Act of 1934, that trading in the securities of the abovelisted company is suspended for the period from 9:30 a.m. EDT on June 17, 2015, through 11:59 p.m. EDT on June 30, 2015. By the Commission. Jill M. Peterson, Assistant Secretary. [FR Doc. 2015–15223 Filed 6–17–15; 11:15 am] BILLING CODE 8011–01–P SECURITIES AND EXCHANGE COMMISSION BILLING CODE 8011–01–P [File No. 500–1] SECURITIES AND EXCHANGE COMMISSION [File No. 500–1] June 17, 2015. It appears to the Securities and Exchange Commission (‘‘Commission’’) that there is a lack of current and accurate information concerning the securities of Neologic Animation Inc. (‘‘NANI 1’’) (CIK No. 1371310), a revoked Nevada corporation whose principal place of business is listed as Zhejiang, China because it is delinquent in its periodic filings with the Commission, having not filed any periodic reports since it filed a Form 10–Q for the period ended September 30, 2013. As of June 10, 2015, NANI’s common stock was quoted on OTC Link (previously ‘‘Pink Sheets’’) operated by OTC Markets Group Inc. On May 7, 2015, the Commission’s Division of Corporation Finance sent a delinquency letter to NANI at the address shown in its then-most recent filing in the Commission’s EDGAR system requesting compliance with its periodic filing requirements, which NANI failed to receive because the letter was undeliverable as addressed. NANI thus failed to maintain a valid address on file with the Commission as required by Commission rules (Rule 301 of Regulation S–T, 17 CFR 232.301 and Section 5.4 of EDGAR Filer Manual). To date, NANI has failed to cure its delinquencies. The Commission is of the opinion that the public interest and the protection of CFR 200.30–3(a)(12). short form of the issuer’s name is also its ticker symbol. In the Matter of Enterologics, Inc., Midas Medici Group Holdings, Inc., and SEFE, Inc., Order of Suspension of Trading June 17, 2015. It appears to the Securities and Exchange Commission (‘‘Commission’’) that there is a lack of current and accurate information concerning the securities of Enterologics, Inc. (‘‘ELGO 1’’) (CIK No. 1483731), a revoked Nevada corporation whose principal place of business is listed as St. Paul, Minnesota because it is delinquent in its periodic filings with the Commission, having not filed any periodic reports since it filed a Form 10–Q for the period ended September 30, 2013. As of June 10, 2015, ELGO’s common shares were quoted on OTC Link (previously ‘‘Pink Sheets’’) operated by OTC Markets Group Inc. (‘‘OTC Link’’). On November 18, 2014, the Commission’s Division of Corporation Finance sent a delinquency letter to ELGO at the address shown in its then-most recent filing in the Commission’s EDGAR system requesting compliance with its periodic filing requirements, which ELGO failed to receive because the letter was not deliverable as addressed. ELGO thus failed to maintain a valid address on file with the Commission as required by Commission rules (Rule 301 of Regulation S–T, 17 CFR 232.301 and Section 5.4 of EDGAR Filer Manual). To date, ELGO has failed to cure its delinquencies. It appears to the Securities and Exchange Commission (‘‘Commission’’) that there is a lack of current and accurate information concerning the 17 17 1 The PO 00000 Frm 00123 Fmt 4703 Sfmt 4703 1 The short form of the issuer’s name is also its ticker symbol. E:\FR\FM\19JNN1.SGM 19JNN1 asabaliauskas on DSK5VPTVN1PROD with NOTICES 35422 Federal Register / Vol. 80, No. 118 / Friday, June 19, 2015 / Notices securities of Midas Medici Group Holdings, Inc. (‘‘MMED’’) (CIK No. 1392448), a void Delaware corporation whose principal place of business is listed as New York, New York because it is delinquent in its periodic filings with the Commission, having not filed any periodic reports since it filed a Form 10–Q for the period ended September 30, 2012. As of June 10, 2015, MMED’s common stock was quoted on OTC Link. On June 6, 2014, the Commission’s Division of Corporation Finance sent a delinquency letter to MMED at the address shown in its then-most recent filing in the Commission’s EDGAR system requesting compliance with its periodic filing requirements, which MMED received on June 11, 2014. To date, MMED has failed to cure its delinquencies. It appears to the Securities and Exchange Commission (‘‘Commission’’) that there is a lack of current and accurate information concerning the securities of SEFE, Inc. (‘‘SEFE’’) (CIK No. 1321573), a defaulted Nevada corporation whose principal place of business is listed as Phoenix, Arizona because it is delinquent in its periodic filings with the Commission, having not filed any periodic reports since it filed a Form 10–Q for the period ended September 30, 2012. As of June 10, 2015, SEFE’s common stock was quoted on OTC Link. On September 16, 2014, the Commission’s Division of Corporation Finance sent a delinquency letter to SEFE at the address shown in its then-most recent filing in the Commission’s EDGAR system requesting compliance with its periodic filing requirements, which SEFE received on September 19, 2014. To date, SEFE has failed to cure its delinquencies. The Commission is of the opinion that the public interest and the protection of investors require a suspension of trading in the securities of the above-listed companies. Therefore, it is ordered, pursuant to Section 12(k) of the Securities Exchange Act of 1934, that trading in the securities of the abovelisted companies is suspended for the period from 9:30 a.m. EDT on June 17, 2015, through 11:59 p.m. EDT on June 30, 2015. By the Commission. Jill M. Peterson, Assistant Secretary. [FR Doc. 2015–15229 Filed 6–17–15; 11:30 am] BILLING CODE 8011–01–P VerDate Sep<11>2014 19:33 Jun 18, 2015 Jkt 235001 SECURITIES AND EXCHANGE COMMISSION [File No. 500–1] In the Matter of Oraco Resources, Inc., SaviCorp (a/k/a SaVi Media Group, Inc.), Smoky Market Foods, Inc., Soltera Mining Corp., and Wolverine Holding Corp. (a/k/a Mobility Plus Medical Equipment, Inc.); Order of Suspension of Trading June 17, 2015. It appears to the Securities and Exchange Commission (‘‘Commission’’) that there is a lack of current and accurate information concerning the securities of Oraco Resources, Inc. (‘‘ORAC 1’’) (CIK No. 1490711), a Nevada corporation whose principal place of business is listed as Rochester, New York because it is delinquent in its periodic filings with the Commission, having not filed any periodic reports since it filed a Form 10–Q for the period ended September 30, 2012. As of June 10, 2015, ORAC’s common stock was quoted on OTC Link (previously ‘‘Pink Sheets’’) operated by OTC Markets Group Inc. (‘‘OTC Link’’). On June 6, 2014, the Commission’s Division of Corporation Finance sent a delinquency letter to ORAC at the address shown in its then-most recent filing in the Commission’s EDGAR system requesting compliance with its periodic filing requirements, which ORAC received on June 9, 2014. To date, ORAC has failed to cure its delinquencies. It appears to the Securities and Exchange Commission (‘‘Commission’’) that there is a lack of current and accurate information concerning the securities of SaviCorp (a/k/a SaVi Media Group, Inc.) (‘‘SVMI’’) (CIK No. 1096637), a Nevada corporation whose principal place of business is listed as Santa Ana, California because it is delinquent in its periodic filings with the Commission, having not filed any periodic reports since it filed a Form 10–K for the period ended December 31, 2013. As of June 10, 2015, SVMI’s common stock was quoted on OTC Link. On January 31, 2013, the Commission’s Division of Corporation Finance sent a delinquency letter to SVMI at the address shown in its then-most recent filing in the Commission’s EDGAR system requesting compliance with its periodic filing requirements, which SVMI received on February 4, 2013. To date, SVMI has failed to cure its delinquencies. 1 The short form of the issuer’s name is also its ticker symbol. PO 00000 Frm 00124 Fmt 4703 Sfmt 4703 It appears to the Securities and Exchange Commission (‘‘Commission’’) that there is a lack of current and accurate information concerning the securities of Smoky Market Foods, Inc. (‘‘SMKY’’) (CIK No. 1370544), a Nevada corporation whose principal place of business is listed as Webster City, Iowa because it is delinquent in its periodic filings with the Commission, having not filed any periodic reports since it filed a Form 10–Q for the period ended September 30, 2014. As of June 10, 2015, SMKY’s common stock was quoted on OTC Link. On September 16, 2014, the Commission’s Division of Corporation Finance sent a delinquency letter to SMKY at the address shown in its then-most recent filing in the Commission’s EDGAR system requesting compliance with its periodic filing requirements, which SMKY received on September 19, 2014. To date, SMKY has failed to cure its delinquencies. It appears to the Securities and Exchange Commission (‘‘Commission’’) that there is a lack of current and accurate information concerning the securities of Soltera Mining Corp. (‘‘SLTA’’) (CIK No. 1348610), a defaulted Nevada corporation whose principal place of business is listed as Santa Ana, California because it is delinquent in its periodic filings with the Commission, having not filed any periodic reports since it filed a Form 10–K for the period ended October 31, 2013. As of June 10, 2015, SLTA’s common stock was quoted on OTC Link. On March 19, 2015, the Commission’s Division of Corporation Finance sent a delinquency letter to SLTA at the address shown in its then-most recent filing in the Commission’s EDGAR system requesting compliance with its periodic filing requirements, which SLTA received on March 24, 2015. To date, SLTA has failed to cure its delinquencies. It appears to the Securities and Exchange Commission (‘‘Commission’’) that there is a lack of current and accurate information concerning the securities of Wolverine Holding Corp. (a/k/a Mobility Plus Medical Equipment, Inc.) (‘‘WLVH’’) (CIK No. 18886), a Delaware corporation whose principal place of business is listed as Smyrna, Georgia because it is delinquent in its periodic filings with the Commission, having not filed any periodic reports since it filed a Form 10–Q for the period ended September 30, 2012. As of June 10, 2015, WLVH’s common stock was quoted on OTC Link. On March 23, 2015, the Commission’s Division of Corporation Finance sent a delinquency letter to WLVH at the E:\FR\FM\19JNN1.SGM 19JNN1

Agencies

SECURITIES AND EXCHANGE COMMISSION

[Federal Register Volume 80, Number 118 (Friday, June 19, 2015)]
[Notices]
[Pages 35421-35422]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-15229]


-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[File No. 500-1]


 In the Matter of Enterologics, Inc., Midas Medici Group 
Holdings, Inc., and SEFE, Inc., Order of Suspension of Trading

June 17, 2015.
    It appears to the Securities and Exchange Commission 
(``Commission'') that there is a lack of current and accurate 
information concerning the securities of Enterologics, Inc. (``ELGO 
\1\'') (CIK No. 1483731), a revoked Nevada corporation whose principal 
place of business is listed as St. Paul, Minnesota because it is 
delinquent in its periodic filings with the Commission, having not 
filed any periodic reports since it filed a Form 10-Q for the period 
ended September 30, 2013. As of June 10, 2015, ELGO's common shares 
were quoted on OTC Link (previously ``Pink Sheets'') operated by OTC 
Markets Group Inc. (``OTC Link''). On November 18, 2014, the 
Commission's Division of Corporation Finance sent a delinquency letter 
to ELGO at the address shown in its then-most recent filing in the 
Commission's EDGAR system requesting compliance with its periodic 
filing requirements, which ELGO failed to receive because the letter 
was not deliverable as addressed. ELGO thus failed to maintain a valid 
address on file with the Commission as required by Commission rules 
(Rule 301 of Regulation S-T, 17 CFR 232.301 and Section 5.4 of EDGAR 
Filer Manual). To date, ELGO has failed to cure its delinquencies.
---------------------------------------------------------------------------

    \1\ The short form of the issuer's name is also its ticker 
symbol.
---------------------------------------------------------------------------

    It appears to the Securities and Exchange Commission 
(``Commission'') that there is a lack of current and accurate 
information concerning the

[[Page 35422]]

securities of Midas Medici Group Holdings, Inc. (``MMED'') (CIK No. 
1392448), a void Delaware corporation whose principal place of business 
is listed as New York, New York because it is delinquent in its 
periodic filings with the Commission, having not filed any periodic 
reports since it filed a Form 10-Q for the period ended September 30, 
2012. As of June 10, 2015, MMED's common stock was quoted on OTC Link. 
On June 6, 2014, the Commission's Division of Corporation Finance sent 
a delinquency letter to MMED at the address shown in its then-most 
recent filing in the Commission's EDGAR system requesting compliance 
with its periodic filing requirements, which MMED received on June 11, 
2014. To date, MMED has failed to cure its delinquencies.
    It appears to the Securities and Exchange Commission 
(``Commission'') that there is a lack of current and accurate 
information concerning the securities of SEFE, Inc. (``SEFE'') (CIK No. 
1321573), a defaulted Nevada corporation whose principal place of 
business is listed as Phoenix, Arizona because it is delinquent in its 
periodic filings with the Commission, having not filed any periodic 
reports since it filed a Form 10-Q for the period ended September 30, 
2012. As of June 10, 2015, SEFE's common stock was quoted on OTC Link. 
On September 16, 2014, the Commission's Division of Corporation Finance 
sent a delinquency letter to SEFE at the address shown in its then-most 
recent filing in the Commission's EDGAR system requesting compliance 
with its periodic filing requirements, which SEFE received on September 
19, 2014. To date, SEFE has failed to cure its delinquencies.
    The Commission is of the opinion that the public interest and the 
protection of investors require a suspension of trading in the 
securities of the above-listed companies. Therefore, it is ordered, 
pursuant to Section 12(k) of the Securities Exchange Act of 1934, that 
trading in the securities of the above-listed companies is suspended 
for the period from 9:30 a.m. EDT on June 17, 2015, through 11:59 p.m. 
EDT on June 30, 2015.

    By the Commission.
Jill M. Peterson,
Assistant Secretary.
[FR Doc. 2015-15229 Filed 6-17-15; 11:30 am]
 BILLING CODE 8011-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.